Eco R1 Capital, LLC Kura Oncology, Inc. Transaction History
Eco R1 Capital, LLC
- $2.83 Billion
- Q2 2024
A detailed history of Eco R1 Capital, LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Eco R1 Capital, LLC holds 5,806,871 shares of KURA stock, worth $113 Million. This represents 4.23% of its overall portfolio holdings.
Number of Shares
5,806,871
Previous 5,806,871
-0.0%
Holding current value
$113 Million
Previous $124 Million
3.47%
% of portfolio
4.23%
Previous 3.53%
Shares
13 transactions
Others Institutions Holding KURA
# of Institutions
181Shares Held
80.2MCall Options Held
148KPut Options Held
63K-
Suvretta Capital Management, LLC New York, NY7.07MShares$138 Million6.08% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$136 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY5.41MShares$106 Million2.34% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY4.54MShares$88.6 Million3.78% of portfolio
-
Bvf Inc San Francisco, CA4.08MShares$79.7 Million2.57% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $1.31B
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...